Cargando…

SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer

PURPOSE: Secreted frizzled-related protein 4 (SFRP4) is a member of the SFRP family, which functions as either a tumor suppressor or a prooncogenic factor in distinct tumor types. Our research aimed to explore the expression of SFRP4 in gastric cancer, its prognostic significance, and its relationsh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Pengcheng, He, Weiyang, Zhang, Yanqiang, Hu, Can, Wu, Yue, Wang, Yi, Bao, Zhehan, Xia, Yuhang, Zhang, Ruolan, Cao, Mengxuan, Yuan, Li, Cheng, Xiangdong, Xu, Zhiyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277207/ https://www.ncbi.nlm.nih.gov/pubmed/35847366 http://dx.doi.org/10.1155/2022/8829649

Ejemplares similares

Preoperative chemotherapy combined with para-aortic lymph node dissection has clinical value in the treatment of gastric cancer with para-aortic lymph node metastases
por: Yu, Pengcheng, et al.
Publicado: (2022)

Prognostic significance of inflammatory and nutritional markers in perioperative period for patients with advanced gastric cancer
por: Zhang, Ruolan, et al.
Publicado: (2023)

High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer
por: Bao, Zhehan, et al.
Publicado: (2022)

Prognostic significance of serum tumor marker normalization in the perioperative period for patients with advanced gastric cancer
por: Hu, Can, et al.
Publicado: (2022)

A Novel Method for Dynamically Assessing the Prognosis of Patients with pT1 Gastric Cancer: A Large Population-Based Dynamic Prognostic Analysis
por: Pan, Siwei, et al.
Publicado: (2023)

High HDAC5 expression correlates with a poor prognosis and the tumor immune microenvironment in gastric cancer
por: Yuan, Li, et al.
Publicado: (2022)

CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer
por: Yuan, Li, et al.
Publicado: (2022)

Aberrant Expression TFR1/CD71 in Gastric Cancer Identifies a Novel Potential Prognostic Marker and Therapeutic Target
por: Cao, Jielu, et al.
Publicado: (2022)

DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients
por: Liu, Xinyan, et al.
Publicado: (2019)

Deep learning radio-clinical signatures for predicting neoadjuvant chemotherapy response and prognosis from pretreatment CT images of locally advanced gastric cancer patients
por: Hu, Can, et al.
Publicado: (2023)

High expression of ceramide synthase 5 predicts a poor prognosis in gastric cancer
por: Zhang, Shengjie, et al.
Publicado: (2022)

Comprehensive Analysis of SFRP Family Members Prognostic Value and Immune Infiltration in Gastric Cancer
por: Liu, Dehua, et al.
Publicado: (2021)

High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis
por: Lai, Hong-Yue, et al.
Publicado: (2022)

Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients
por: Yuan, Mingjie, et al.
Publicado: (2022)

Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma
por: Sremac, Maja, et al.
Publicado: (2021)

SFRP2 is a Novel Diagnostic Biomarker and Suppresses the Proliferation of Pituitary Adenoma
por: Huang, Rongxi, et al.
Publicado: (2022)

Feasibility of Plasma-Methylated SFRP2 for Early Detection of Gastric Cancer
por: Miao, Jin, et al.
Publicado: (2020)

SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence
por: Busuttil, Rita A., et al.
Publicado: (2020)

A literature review on the potential clinical implications of streptococci in gastric cancer
por: Zi, Mengli, et al.
Publicado: (2022)

Cell differentiation trajectory predicts patient potential immunotherapy response and prognosis in gastric cancer
por: Xiang, Renshen, et al.
Publicado: (2021)

The value of metabolic LncRNAs in predicting prognosis and immunotherapy efficacy of gastric cancer
por: Du, Peizhun, et al.
Publicado: (2023)

Concurrent Hypermethylation of SFRP2 and DKK2 Activates the Wnt/β-Catenin Pathway and Is Associated with Poor Prognosis in Patients with Gastric Cancer
por: Wang, Hao, et al.
Publicado: (2017)

Hyperactivated Wnt-β-catenin signaling in the absence of sFRP1 and sFRP5 disrupts trophoblast differentiation through repression of Ascl2
por: Bao, Haili, et al.
Publicado: (2020)

In Silico identification of novel phytochemicals that target SFRP4: An early biomarker of diabesity
por: Rehman, Asim, et al.
Publicado: (2023)

Promoter Methylation of SFRP3 Is Frequent in Hepatocellular Carcinoma
por: Lin, Ya-Wen, et al.
Publicado: (2014)

Glutathione peroxidase 2 knockdown suppresses gastric cancer progression and metastasis via regulation of kynurenine metabolism
por: Xu, Handong, et al.
Publicado: (2023)

Diagnostic Value of SFRP1 as a Favorable Predictive and Prognostic Biomarker in Patients with Prostate Cancer
por: Zheng, Lei, et al.
Publicado: (2015)

Study of SFRP1 and SFRP2 methylation status in patients with de novo Acute Myeloblastic Leukemia
por: Ghasemi, Ali, et al.
Publicado: (2015)

Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival
por: Majchrzak-Celińska, Aleksandra, et al.
Publicado: (2015)

Retracted: SFRP2 is a Novel Diagnostic Biomarker and Suppresses the Proliferation of Pituitary Adenoma
por: Journal of Oncology
Publicado: (2023)

Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer
por: ZHANG, XIE, et al.
Publicado: (2014)

The role of dexamethasone in mediating the contradictory effects of Wnt antagonists SFRP2 and SFRP3 on human hair follicle growth
por: Hamida, Ons Ben, et al.
Publicado: (2023)

Polyphyllin B Suppresses Gastric Tumor Growth by Modulating Iron Metabolism and Inducing Ferroptosis
por: Hu, Can, et al.
Publicado: (2023)

Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer
por: Zhao, Chenghai, et al.
Publicado: (2009)

The Wnt Antagonist sFRP1 as a Favorable Prognosticator in Human Biliary Tract Carcinoma
por: Kang, Pengcheng, et al.
Publicado: (2014)

The role of Sfrp and DKK proteins in cardiomyocyte development
por: Hsueh, Ying‐Chang, et al.
Publicado: (2021)

EZH2 regulates sFRP4 expression without affecting the methylation of sFRP4 promoter DNA in colorectal cancer cell lines
por: Liu, Yuting, et al.
Publicado: (2020)

The current management and biomarkers of immunotherapy in advanced gastric cancer
por: Chang, Xiaojing, et al.
Publicado: (2022)

SFRP Tumour Suppressor Genes Are Potential Plasma-Based Epigenetic Biomarkers for Malignant Pleural Mesothelioma
por: Cheng, Yuen Yee, et al.
Publicado: (2017)

LUCAT1 Epigenetically Downregulates the Tumor Suppressor Genes CXXC4 and SFRP2 in Gastric Cancer
por: Byun, Hyo Joo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2p0hnnbr19uprqlf1v353g7chn